Cargando…

A Review on the Impact of Body Mass Index on Outcomes in Pediatric Leukemia

In the last decades, adults and pediatric obesity have become a major issue in developed countries. Considerable research has been conducted in patients with acute lymphoblastic (ALL) and myeloid leukemia (AML) with the aim of correlating body mass index (BMI) and outcomes in patients undergoing che...

Descripción completa

Detalles Bibliográficos
Autor principal: Paviglianiti, Annalisa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7308124/
https://www.ncbi.nlm.nih.gov/pubmed/32607038
http://dx.doi.org/10.2147/JBM.S232655
_version_ 1783548935262961664
author Paviglianiti, Annalisa
author_facet Paviglianiti, Annalisa
author_sort Paviglianiti, Annalisa
collection PubMed
description In the last decades, adults and pediatric obesity have become a major issue in developed countries. Considerable research has been conducted in patients with acute lymphoblastic (ALL) and myeloid leukemia (AML) with the aim of correlating body mass index (BMI) and outcomes in patients undergoing chemotherapy for hematological diseases. In adults, a high BMI has been associated with increased leukemia-related mortality. Whether a similar effect exists in the pediatric setting remains controversial. Some of the studies detailed in this review have reported no differences in outcomes according to BMI, whilst other reports have described higher treatment-related mortality, increased risk of relapse and death. Although the link between BMI and acute leukemia outcomes is controversial, a large number of studies describe poorer survival rates in children with AML or ALL with higher BMI. On the other hand, being underweight has been associated with higher treatment-related toxicity. Understanding more about the impact of BMI in pediatric leukemia is of utmost importance to provide prompt intervention and improve outcomes.
format Online
Article
Text
id pubmed-7308124
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-73081242020-06-29 A Review on the Impact of Body Mass Index on Outcomes in Pediatric Leukemia Paviglianiti, Annalisa J Blood Med Review In the last decades, adults and pediatric obesity have become a major issue in developed countries. Considerable research has been conducted in patients with acute lymphoblastic (ALL) and myeloid leukemia (AML) with the aim of correlating body mass index (BMI) and outcomes in patients undergoing chemotherapy for hematological diseases. In adults, a high BMI has been associated with increased leukemia-related mortality. Whether a similar effect exists in the pediatric setting remains controversial. Some of the studies detailed in this review have reported no differences in outcomes according to BMI, whilst other reports have described higher treatment-related mortality, increased risk of relapse and death. Although the link between BMI and acute leukemia outcomes is controversial, a large number of studies describe poorer survival rates in children with AML or ALL with higher BMI. On the other hand, being underweight has been associated with higher treatment-related toxicity. Understanding more about the impact of BMI in pediatric leukemia is of utmost importance to provide prompt intervention and improve outcomes. Dove 2020-06-18 /pmc/articles/PMC7308124/ /pubmed/32607038 http://dx.doi.org/10.2147/JBM.S232655 Text en © 2020 Paviglianiti. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Review
Paviglianiti, Annalisa
A Review on the Impact of Body Mass Index on Outcomes in Pediatric Leukemia
title A Review on the Impact of Body Mass Index on Outcomes in Pediatric Leukemia
title_full A Review on the Impact of Body Mass Index on Outcomes in Pediatric Leukemia
title_fullStr A Review on the Impact of Body Mass Index on Outcomes in Pediatric Leukemia
title_full_unstemmed A Review on the Impact of Body Mass Index on Outcomes in Pediatric Leukemia
title_short A Review on the Impact of Body Mass Index on Outcomes in Pediatric Leukemia
title_sort review on the impact of body mass index on outcomes in pediatric leukemia
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7308124/
https://www.ncbi.nlm.nih.gov/pubmed/32607038
http://dx.doi.org/10.2147/JBM.S232655
work_keys_str_mv AT paviglianitiannalisa areviewontheimpactofbodymassindexonoutcomesinpediatricleukemia
AT paviglianitiannalisa reviewontheimpactofbodymassindexonoutcomesinpediatricleukemia